Literature DB >> 31853710

BAG3 p.Pro209Ser mutation identified in a Chinese family with Charcot-Marie-Tooth disease.

Jun Fu1, Mingming Ma1, Jia Song1, Mi Pang1, Gang Li1, Jiewen Zhang2.   

Abstract

Bcl2-associated athanogene 3 (BAG3) gene mutations cause dilated cardiomyopathy and myofibrillar myopathy. Recently, a novel c.625C>T (p.Pro209Ser) mutation in BAG3 was reported to cause axonal Charcot-Marie-Tooth (CMT) disease in three families. Here, we describe two patients with adult-onset and moderate CMT in a Chinese family. Nerve conduction velocity studies revealed an axonal sensorimotor neuropathy, which was supported by sural nerve biopsy. Lower limb magnetic resonance imaging (MRI) revealed fatty infiltration more severe in the soleus and deep posterior compartment muscles than in the medial gastrocnemius and anterior compartment muscles. Whole exome sequencing identified the same c.625C>T (p.Pro209Ser) mutation in BAG3, which co-segregated with the CMT disease in this family. This study further enforces the association between BAG3 gene and CMT disease, indicating that BAG3 should be considered in the genetic testing for CMT. The p.Pro209Ser mutation with different ethnic origins might be another hotspot mutation of BAG3. MRI is helpful to detect accurate extent of muscle involvement.

Entities:  

Keywords:  Axonal; BAG3; Charcot–Marie–Tooth disease; Hotspot mutation; MRI; Nerve biopsy

Year:  2019        PMID: 31853710     DOI: 10.1007/s00415-019-09680-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis.

Authors:  Lara Marie Pangan Lo; Bruce V Taylor; Tania Winzenberg; Andrew J Palmer; Leigh Blizzard; Ingrid van der Mei
Journal:  J Neurol       Date:  2020-09-03       Impact factor: 4.849

Review 2.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

3.  High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.

Authors:  Jorge Maurino; Javier Sotoca; Ángel P Sempere; Luis Brieva; Carlos López de Silanes; Ana B Caminero; María Terzaghi; Julia Gracia-Gil; Gustavo Saposnik
Journal:  Patient       Date:  2020-09-25       Impact factor: 3.883

Review 4.  The role of BAG3 in health and disease: A "Magic BAG of Tricks".

Authors:  Heng Lin; Shon A Koren; Gregor Cvetojevic; Peter Girardi; Gail V W Johnson
Journal:  J Cell Biochem       Date:  2021-05-14       Impact factor: 4.480

5.  B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF.

Authors:  Maha M Bakhuraysah; Paschalis Theotokis; Jae Young Lee; Amani A Alrehaili; Pei-Mun Aui; William A Figgett; Michael F Azari; John-Paul Abou-Afech; Fabienne Mackay; Christopher Siatskas; Frank Alderuccio; Stephen M Strittmatter; Nikolaos Grigoriadis; Steven Petratos
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.996

Review 6.  Next-Generation Sequencing Technologies and Neurogenetic Diseases.

Authors:  Hui Sun; Xiao-Rong Shen; Zi-Bing Fang; Zong-Zhi Jiang; Xiao-Jing Wei; Zi-Yi Wang; Xue-Fan Yu
Journal:  Life (Basel)       Date:  2021-04-19

7.  BAG3-related myofibrillar myopathy: a further observation with cardiomyopathy at onset in pediatric age.

Authors:  Gaia Scarpini; Maria Lucia Valentino; Melania Giannotta; Luca Ragni; Annalaura Torella; Marta Columbaro; Vincenzo Nigro; Antonella Pini
Journal:  Acta Myol       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.